BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Policy

  Ex-Theranos COO Sunny Balwani Found Guilty on 12 Fraud Charges

  Ramesh “Sunny” Balwani, Elizabeth Holmes’ former business and romantic partner, was found guilty of all 12 fraud charges brought against him for his role in the Theranos scandal.

  July 8, 2022

   · 

  2 min read

   · 

  Alex Keown
• 

  Employer Resources

  Working Moms: Redefining Success & Finding Balance in the Life Sciences

  With one in three employed women in the U.S. also raising children at home, and the majority of U.S. moms working at least part-time, moms are working overtime to keep up with their male counterparts.

  July 8, 2022

   · 

  5 min read

   · 

  Justin Krivda
• 

  SPONSORED: Taking the Headache out of Unpredictable Production Requirements with Scalable Solutions

  Discover how Eppendorf OEM worked with the market leader in laboratory automation to develop a win-win business model and 25-year partnership.

  July 8, 2022

   · 

  1 min read

   · 

  Sponsored Content
• 

  Rational’s Experimental Herpes Vaccine Shows Preclinical Promise

  Rational Vaccines said findings from a pilot study showed that RVX201 led to a reduction in recurrent genital lesions when compared to gD2-alum/MPL vaccine in animal studies.

  July 8, 2022

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  AbbVie Half Breaks Up with Alector on Alzheimer’s

  In a filing with the SEC, Abbvie’s decision to terminate came after the two firms jointly conducted a review of their next steps for the drug.

  July 8, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Drug Development

  Millions of COVID-19 Shots Discarded, while Intermittent Fasting Could Curb Serious Disease

  With COVID-19 vaccination rates dropping, millions of doses are going to waste. Meanwhile, outdoors isn’t sure-fire protection but long-term intermittent fasters may be spared severe disease.

  July 8, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  Adverum Slashes Workforce By 38%, Hones In On Eye Disease Candidate

  Adverum Biotechnologies is cutting 78 jobs after announcing it had successfully amended its Investigational New Drug application for ADVM-022.to treat wet age-related macular degeneration.

  July 8, 2022

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Drug Development

  Clinical Catch-Up: Vertex, Ayala, Arrowhead, Dyne & More

  Ayala announced positive data for its desmoid tumor treatment, while Vertex and Dyne announced the FDA had lifted the hold on their clinical studies.

  July 8, 2022

   · 

  5 min read

   · 

  Mark Terry
• 

  Policy

  Two-Thirds of 2021 FDA-Approved Drugs Supported with Genetic Data

  Last year, the FDA’s Center for Drug Evaluation and Research approved 50 drugs. A new study found that 33, or 66% of them, were supported with genomic data.

  July 8, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  On Cusp of Merck Acquisition, Seagen Makes Waves in Colorectal Cancer

  Seagen recently presented positive pivotal Phase II data from its trial of Tukysa (tucatinib) in combination with trastuzumab in HER2-positive metastatic colorectal cancer.

  July 8, 2022

   · 

  5 min read

   · 

  Hayley Shasteen